Document is current
Any future updates will be listed below
-
Authors
Jeong, Hyeonjeong
Christenson, Peter R.
Ahn, Hyerim
Lashuel, Hilal A.
Larsen, Peter A.
Oh, Sang-Hyun
Park, Hye Yoon
-
Funding
Funding for this research was provided by:
State of Minnesota (ML23, Chapter 41, Art 1, Sec 4, Subd.4e)
State of Minnesota (ML23, Chapter 41, Art 1, Sec 4, Subd.4e)
State of Minnesota (ML23, Chapter 41, Art 1, Sec 4, Subd.4e)
Michael J. Fox Foundation for Parkinson's Research (Not applicable)
University of Minnesota (Not applicable)
University of Minnesota (Not applicable)
- License Information
-
More Information
Article History
Received: 5 February 2026
Accepted: 5 July 2026
First Online: 29 July 2026
Ethics
Competing interests: P.R.C., P.A.L., and S.-H.O. are co-inventors on a patent related to the Nano-QuIC assay. P.A.L. and S.-H.O. are co-founders and equity holders of Priogen Corp., a diagnostic company specializing in the detection for prions and protein misfolding diseases. H.A.L. is a co-founder and chief scientific officer of ND BioSciences SA, a company focusing on developing novel therapies and diagnostics for neurodegenerative diseases. The other authors do not have a competing interest.
